Suzanne Albustan

Prof. Suzanne Albustan

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
SASuzanne Albustan
Suzanne Albustan
MEMokhtar El-Zawahri
Mokhtar El-Zawahri
DADaleil Al-Azmi
Daleil Al-Azmi
AAAbdul-Aziz Al-Bashir
Abdul-Aziz Al-Bashir

1 August 2002 in Orthodontics & Craniofacial Research
Verified
Journal Article
Closed access
PDF file
SASuzanne Albustan
Suzanne Albustan
MEM M El‐Zawahri
M M El‐Zawahri
Amani Mustafa Al-AdsaniAmani Mustafa Al-Adsani
Amani Mustafa Al-Adsani
RBR L Bang
R L Bang
IGI Ghunaim
I Ghunaim
AMA M
A M

25 September 2014 in Journal of Human Genetics
Verified
Journal Article
Closed access
XYXiong Yang
Xiong Yang
SASuzanne Albustan
Suzanne Albustan
QFQidi Feng
Qidi Feng
WGWei Guo
Wei Guo
ZMZhiming Ma
Zhiming Ma
SXShuhua Xu
Shuhua Xu

23 January 2018 in Medical Principles and Practice
Verified
Journal Article
Open access
PDF file
AAAhmad Al-Serri
Ahmad Al-Serri
SASuzanne Albustan
Suzanne Albustan
MKMaisa Kamkar
Maisa Kamkar
DTDaisy Thomas
Daisy Thomas
OAOsama Alsmadi
Osama Alsmadi
NANabila A. Abdella
Nabila A. Abdella
Objective: To investigate the effect of the common fat mass and obesity-associated (FTO) gene polymorphism rs9939609 on body mass index (BMI) in one of the most obese populations worldwide. Subjects and Methods: Genotypic data for FTO rs9939609 were available for 1,034 unrelated Kuwaiti adults obtained from Kuwait’s Dasman Diabetes Institute and Kuwait University. The association between the FTO polymorphism with BMI as continuous and categorical (normal BMI [< 25] vs. overweight/obese [> 25]) variables was analyzed using both linear and logistic regression models, respectively, with the assumption of both dominant and additive genetic models performed using the SNPassoc package from R statistics. Results: The A allele was associated with increased BMI (β = 1.21; 95% CI = 0.16–2.26; p = 0.023). In concordance, the categorical BMI (normal vs. overweight/obese) also showed a significant association between the A allele and overweight/obesity (OR = 1.47; 95% CI = 1.01–2.12; p = 0.041). However, no association between the FTO variant was observed with cardiometabolic traits. Conclusion: We observed an association between the common FTO rs9939609 polymorphism and increased BMI (overweight/obesity) in Kuwaiti adults, which is consistent with previous research in other populations. Our findings encourage further investigation of genetic variants to elucidate the mechanisms involved in the development of obesity in such an obesogenic population.

12 September 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
SASuzanne Albustan
Suzanne Albustan
AAAhmad E Al-Serri
Ahmad E Al-Serri
BABabitha G Annice
Babitha G Annice
MAMajed Alnaqeeb
Majed Alnaqeeb
GEGhada A Ebrahim
Ghada A Ebrahim
APOAI, a member of the APOAI/CIII/IV/V gene cluster on chromosome 11q23-24, encodes a major protein component of HDL that has been associated with serum lipid levels. The aim of this study was to determine the genetic association of polymorphisms in the APOAI promoter region with plasma lipid levels in a cohort of healthy Kuwaiti volunteers.

8 October 2014 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
SASuzanne Albustan
Suzanne Albustan
MAMajed Alnaqeeb
Majed Alnaqeeb
BABabitha G. Annice
Babitha G. Annice
GEGhada A. Ebrahim
Ghada A. Ebrahim
TRThanaa M. Refai
Thanaa M. Refai
Several studies have identified APOB as a candidate gene predisposing individuals to dyslipidemia. Polymorphisms including the signal peptide (rs11279109), codon 2488 XbaI (rs1042031), codon 3611 MspI (rs693), codon 4154 EcoRI (rs1801701) and the 3’ variable number of tandem repeats have been reported to be associated with dyslipidemia in several populations. With limited studies on Arabs, this study aimed to investigate the genetic association of APOB polymorphisms and assess the potential influence of minor and rare alleles on serum lipid levels in the Kuwaiti population. A total of 795 Kuwaiti subjects, documented with phenotypic data and fasting serum lipid levels, were genotyped for the five polymorphisms using PCR, PCR-RFLP and gene fragment analysis. Genotype and allele association with variation in serum lipid levels as well as haplotypes were analyzed using chi-square test, univariate and logistic regression analysis. Analysis of the genotype and allele frequencies distribution revealed a significant positive association between the APOB signal peptide and 3611 MspI polymorphisms with increased levels of triglycerides (statistical power of 80%). Haplotype analysis further supported the findings by showing that carriers of haplotypes (IX−M−E+M) had significantly lower mean (SD) TG levels (0.86 ± 0.07) as compared to non-carriers (1.01 ± 0.02). Significance was also observed with regards to positive family history of hypercholesterolemia. The results imply a “protective role” for two alleles (rs11279109 and rs1801701) in which logistic regression analysis showed a significant half–fold decrease in the risk for heterozygotes of rs11279109 and an 8.8 fold decrease in the risk for homozygous M−M− of rs1801701 of having lower TG levels (<1.70 mmol/L) in individuals. This suggests that genetic interaction between various polymorphisms at different gene loci act in linkage disequilibrium to affect serum TG levels. Apo B genotyping may be a useful adjunct for the identification of individuals at risk of developing dyslipidemia in order to provide them with lifestyle modifications and/or pharmacological intervention to mitigate the effects of gene interaction and environmental influence.